Publication Information

{'id': 'https://openalex.org/W2388825225', 'doi': None, 'title': 'PLASMA 9-HYDROXYRISPRRIDONE LEVEL OF RISPERIDONE′S ACTIVE METABOLITE AND ITS CLINICAL SIGNIFICANCE', 'display_name': 'PLASMA 9-HYDROXYRISPRRIDONE LEVEL OF RISPERIDONE′S ACTIVE METABOLITE AND ITS CLINICAL SIGNIFICANCE', 'publication_year': 2004, 'publication_date': '2004-01-01', 'ids': {'openalex': 'https://openalex.org/W2388825225', 'mag': '2388825225'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-XYZL200406015.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764427353', 'display_name': 'Journal of Jiangsu Clinical Medicine', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5100379590', 'display_name': 'Xiaobin Zhang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I78978612', 'display_name': 'Yangzhou University', 'ror': 'https://ror.org/03tqb8s11', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I78978612']}], 'countries': ['CN'], 'is_corresponding': True, 'raw_author_name': 'Zhang Xiao-bin', 'raw_affiliation_strings': ['Department of Psychiatry, Affiliated Yangzhou Wutaishan Hospita of Medical Coll ege of   Yangzhou University, Yangzhou, Jiangsu 225003)'], 'affiliations': [{'raw_affiliation_string': 'Department of Psychiatry, Affiliated Yangzhou Wutaishan Hospita of Medical Coll ege of   Yangzhou University, Yangzhou, Jiangsu 225003)', 'institution_ids': ['https://openalex.org/I78978612']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5100379590'], 'corresponding_institution_ids': ['https://openalex.org/I78978612'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Natural Compounds', 'score': 0.9815, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Natural Compounds', 'score': 0.9815, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13105', 'display_name': 'Synthesis and pharmacology of benzodiazepine derivatives', 'score': 0.98, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T14331', 'display_name': 'Medicinal Plant Pharmacodynamics Research', 'score': 0.9511, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/plasma-levels', 'display_name': 'Plasma levels', 'score': 0.50668436}, {'id': 'https://openalex.org/keywords/active-metabolite', 'display_name': 'Active metabolite', 'score': 0.48880288}, {'id': 'https://openalex.org/keywords/clinical-practice', 'display_name': 'Clinical Practice', 'score': 0.47607416}, {'id': 'https://openalex.org/keywords/clinical-significance', 'display_name': 'Clinical Significance', 'score': 0.46084735}], 'concepts': [{'id': 'https://openalex.org/C2780057945', 'wikidata': 'https://www.wikidata.org/wiki/Q412443', 'display_name': 'Risperidone', 'level': 3, 'score': 0.972026}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.73806775}, {'id': 'https://openalex.org/C2776412080', 'wikidata': 'https://www.wikidata.org/wiki/Q7431605', 'display_name': 'Schizophrenia (object-oriented programming)', 'level': 2, 'score': 0.66372}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5928717}, {'id': 'https://openalex.org/C3017575891', 'wikidata': 'https://www.wikidata.org/wiki/Q3918988', 'display_name': 'Plasma levels', 'level': 2, 'score': 0.50668436}, {'id': 'https://openalex.org/C149151106', 'wikidata': 'https://www.wikidata.org/wiki/Q4677569', 'display_name': 'Active metabolite', 'level': 3, 'score': 0.48880288}, {'id': 'https://openalex.org/C2779974597', 'wikidata': 'https://www.wikidata.org/wiki/Q28448986', 'display_name': 'Clinical Practice', 'level': 2, 'score': 0.47607416}, {'id': 'https://openalex.org/C63363279', 'wikidata': 'https://www.wikidata.org/wiki/Q5133848', 'display_name': 'Clinical significance', 'level': 2, 'score': 0.46084735}, {'id': 'https://openalex.org/C3020079912', 'wikidata': 'https://www.wikidata.org/wiki/Q3918988', 'display_name': 'Plasma concentration', 'level': 2, 'score': 0.45275095}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.40489438}, {'id': 'https://openalex.org/C2777477808', 'wikidata': 'https://www.wikidata.org/wiki/Q407595', 'display_name': 'Metabolite', 'level': 2, 'score': 0.3603488}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.26524252}, {'id': 'https://openalex.org/C1862650', 'wikidata': 'https://www.wikidata.org/wiki/Q186005', 'display_name': 'Physical therapy', 'level': 1, 'score': 0.08719307}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-XYZL200406015.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764427353', 'display_name': 'Journal of Jiangsu Clinical Medicine', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.73, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3207213207', 'https://openalex.org/W2791629423', 'https://openalex.org/W2557164840', 'https://openalex.org/W2413334594', 'https://openalex.org/W2390395321', 'https://openalex.org/W2386304628', 'https://openalex.org/W2378616719', 'https://openalex.org/W2370222864', 'https://openalex.org/W2366583741', 'https://openalex.org/W2365171890', 'https://openalex.org/W2361037870', 'https://openalex.org/W2168445796', 'https://openalex.org/W2116935347', 'https://openalex.org/W2088887999', 'https://openalex.org/W2071330308', 'https://openalex.org/W2026993938', 'https://openalex.org/W1994870822', 'https://openalex.org/W1994627117', 'https://openalex.org/W175177365', 'https://openalex.org/W1439445912'], 'abstract_inverted_index': {'Objective': [0], 'To': [1], 'observe': [2], 'the': [3, 14, 58, 103, 122, 137, 151, 166, 177, 198], 'relationship': [4], 'among': [5, 102], 'oral': [6, 76, 113, 159, 172], 'dose,': [7], 'pla': [8], 'sm': [9], 'a': [10], 'drug': [11, 48], 'level': [12, 129, 168, 179], 'and': [13, 70, 80, 90, 108, 176], 'clinical': [15], 'significance': [16], 'of': [17, 50, 60, 75, 78, 83, 96, 115, 125, 130, 161, 169, 174, 180], 'risperidone.': [18], 'Methods': [19], 'The': [20, 46, 63, 73, 93, 112, 127, 158, 171], 'study': [21], 'was': [22, 117, 132, 145, 163], 'conducted': [23], 'in': [24, 140, 154, 185, 190], '56': [25], 'patients': [26, 187, 192], 'with': [27, 121, 136, 150, 165], 'schizophrenia.': [28], 'They': [29], 'were': [30, 52, 65, 85, 99, 183], 'divid': [31], 'ed': [32], 'to': [33], 'receive': [34], '3': [35, 104], 'mg,': [36, 105], '4': [37, 44, 106], 'mg': [38, 41, 107, 110], 'or': [39], '5': [40, 109], 'risperidone': [42, 79, 116, 162, 175], 'for': [43], 'weeks.': [45], 'plasma': [47, 81, 94, 123, 128, 167, 178], 'levels': [49, 82, 95, 124], '9-hydroxyrisperidone': [51, 84, 131], 'measured': [53], 'by': [54], 'HPLC': [55], 'method': [56], 'at': [57, 67], 'end': [59], 'Week': [61, 68], '4.': [62, 71], 'PANSS': [64, 141], 'evaluated': [66], '1': [69], 'Results': [72], 'difference': [74], 'dose': [77, 114, 160, 173], 'sig': [86], 'nificant': [87], 'between': [88], 'male': [89, 191], 'female': [91, 186], 'patients.': [92], '9-hydroxyrisper': [97], 'idone': [98], 'significantly': [100], 'different': [101], 'group.': [111], 'significant': [118, 146], 'positive': [119, 155, 200], 'correlated': [120, 164], '9-hydroxyrisperidone.': [126, 170], 'not': [133], 'corr': [134], 'elation': [135], 'decreased': [138, 152], 'rate': [139, 153], 'total': [142], 'scores': [143], 'but': [144], 'positi': [147], 've': [148], 'correlation': [149], 'scores.': [156], 'Conclusions': [157], '9-': [181], 'hydroxyrisperidone': [182], 'lower': [184], 'than': [188], 'that': [189], 'so': [193], 'r': [194], 'isperidone': [195], 'can': [196], 'improve': [197], 'patient′s': [199], 'symptoms': [201], 'firstly.': [202]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2388825225', 'counts_by_year': [], 'updated_date': '2024-12-24T03:38:42.668432', 'created_date': '2016-06-24'}